| abstract |
The present invention relates to specific novel tetrahydroquinoline-6-carboxamide derivatives, to pharmaceutical compositions containing such compounds, and to their use in therapy as bromodomain inhibitors. Such derivatives may therefore be useful for treating diseases or conditions in which a bromodomain inhibitor is indicated, such as an acute or chronic autoimmune and / or inflammatory condition or cancer. |